What are the contraindications of Lynparza tablets and what you need to know before using them

Olaparib As aPARP inhibitor, it plays an important role in the treatment of BRCA mutation-related ovarian cancer, breast cancer, prostate cancer and other solid tumors. However, as a highly targeted anti-cancer drug, olaparib should pay high attention to its contraindications and risk warnings before use to ensure the greatest balance between efficacy and safety.

First, one of the major contraindications to olaparib is that it should not be used in patients who are allergic to its active ingredient or any excipients. Although allergic reactions are rare, they may have serious consequences if they occur, so a detailed allergy history should be checked before taking the drug for the first time. Secondly, for patients with severe hepatic or renal insufficiency, olaparib should be used with caution or the dosage should be adjusted under strict supervision by a physician. Because drugs are mainly metabolized and excreted by the liver and kidneys, organ dysfunction will affect blood drug concentrations and may increase the risk of adverse reactions.

In addition, olaparib is not recommended for use in pregnant women or women preparing for pregnancy because animal experiments have shown potential embryotoxicity and teratogenic risks. Breastfeeding women should also avoid using it. If you must take it, you need to stop breastfeeding. For patients undergoing chemotherapy and radiotherapy, if olaparib is used concurrently, the risk of additive myelosuppressive effects, including neutropenia, anemia, and thrombocytopenia, needs to be evaluated. Use with extreme caution in any patient with active infection, extremely immunocompromised, or poor bone marrow reserve.

Olaparib has also been found clinically to induce rare but serious adverse reactions, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), especially in long-term users. Therefore, blood routine and liver and kidney functions should be monitored regularly during medication. If abnormalities are found, medication should be discontinued promptly and risks assessed. In addition, because olaparib may affect fatigue levels and cognitive responses, drivers and operators of machinery should adjust their working conditions appropriately based on individual responses.

Reference materials:https://www.lynparza.com/